PCA Investment Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

PCA Investment Advisory Services’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-222	Closed	-$116K	–	387
2023 Q2	$116K	Buy	+222	New	+$120K	0.07%	178

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PCA Investment Advisory Services's TMO Position: Q3 2023 in Review

PCA Investment Advisory Services sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 222 shares — an estimated $116K sold.

PCA Investment Advisory Services first reported a position in TMO in Q2 2023 and held it in 1 quarter. The position peaked at $116K in Q2 2023. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

PCA Investment Advisory Services reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
PCA Investment Advisory Services sold 222 Thermo Fisher Scientific shares in Q3 2023, an estimated $116K.
PCA Investment Advisory Services first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 1 quarter.
PCA Investment Advisory Services's Thermo Fisher Scientific position peaked at $116K in Q2 2023.
2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on PCA Investment Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.